Veterinary Medicines

Isophen D, oplossing voor injectie voor honden en katten

Authorised
  • Phenylbutazone
  • Dexamethasone sodium phosphate
  • Ramifenazone
  • Lidocaine
Download as PDF

Product identification

Medicine name:
Isophen D, oplossing voor injectie voor honden en katten
Active substance:
  • Phenylbutazone
  • Dexamethasone sodium phosphate
  • Ramifenazone
  • Lidocaine
Target species:
  • Dog
  • Cat
Route of administration:
  • Intramuscular use
  • Intravenous use

Product details

Active substance and strength:
  • Phenylbutazone
    65.30
    milligram(s)
    /
    1.00
    millilitre(s)
  • Dexamethasone sodium phosphate
    0.50
    milligram(s)
    /
    1.00
    millilitre(s)
  • Ramifenazone
    140.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Lidocaine
    2.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Dog
    • Cat
  • Intravenous use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QM01BA01
Legal status of supply:
  • Medicinal product subject to medical prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Aesculaap B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Aesculaap B.V.
Responsible authority:
  • MEB
Authorisation number:
  • REG NL 4742
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 23/02/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."